Copyright: ©Author(s) 2026.
World J Psychiatry. Apr 19, 2026; 16(4): 115981
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.115981
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.115981
Table 1 Characteristics of included trials
| Ref. | Samples | Age (mean ± SD) | Intervention/experimental group | Control group | Intervention time/period | Outcomes | |
| Liu and Xiao[44], 2011 | 60 | E: 51.40 ± 8.7 | C: 51.30 ± 6.6 | Modified Xiaoyaosan (n = 30) | Flupentixol and melitracen tablets (n = 30) | 6 weeks | (1) |
| Zhang[49], 2011 | 96 | E: 35-70 | C: 36-69 | Modified Ganmaidazao decoction plus Xiaoyaosan (n = 48) | Alprazolam (n = 48) | 6 weeks | (1)(2)(3) |
| Sun et al[46], 2015 | 58 | E: 45.9 ± 11.7 | C: 58.6 ± 35 | Modified Xiaoyaosan (n = 29) | Flupentixol and melitracen tablets (n = 29) | 6 weeks | (2) |
| Yan et al[47], 2015 | 68 | 38-69 | Modified Xiaoyaosan (n = 34) | Paroxetine hydrochloride tablets (n = 34) | 4 weeks | (1) | |
| Zhang et al[48], 2015 | 60 | E: 40-65 | C: 35-67 | Modified Xiaoyaosan (n = 30) | Fluoxetine hydrochloride tablets (n = 30) | 3 weeks | (1) |
| Jin et al[43], 2016 | 82 | E: 23-65 | C: 24-67 | Fuzhengjieyu decoction (n = 41) | Alprazolam (n = 41) | 10 weeks | (1)(5) |
| Sun et al[36], 2016 | 64 | 24-73 | Modified Xiaoyaosan (n = 32) | No intervention (n = 32) | 6 weeks | (2)(4) | |
| Chang et al[32], 2017 | 84 | E: 39-70 | C: 38-68 | Shuganxiaobi decoction (n = 42) | Fluoxetine hydrochloride tablets (n = 42) | 4 weeks | (1) |
| Shi et al[45], 2017 | 66 | E: 35-68 | C: 32-71 | Modified Chaihuguizhi decoction (n = 36) | Paroxetine hydrochloride tablets (n = 30) | 8 weeks | (1) |
| Hu et al[34], 2018 | 80 | E: 47.37 ± 8.60 | C: 48.23 ± 8.10 | Jiawei Xiaoyao pill (n = 40) | Venlafaxine hydrochloride sustained-release tablets (n = 40) | 1 month | (4) |
| Yang[50], 2018 | 92 | E: 49.12 ± 7.96 | C: 48.86 ± 8.13 | Chaihulonggumuli decoction (n = 46) | Fluoxetine hydrochloride tablets (n = 46) | 1 month | (1) |
| He[33], 2019 | 70 | E: 51.83 ± 8.15 | C: 50.77 ± 9.20 | Danzhixiaoyao powder (n = 35) | Flupentixol and melitracen tablets (n = 35) | 4 weeks | (1) |
| Huang et al[42], 2019 | 77 | E: 46.26 ± 2.32 | C: 45.72 ± 2.05 | Modified Ganmaidazao decoction (n = 39) | Amitriptyline hydrochloride tablets (n = 38) | 4 weeks | (1)(3) |
| Jiang[37], 2019 | 60 | E: 42.08 ± 5.10 | C: 41.93 ± 5.37 | Chaihu plus Longgumuli decotion (n = 30) | Fluoxetine hydrochloride tablets (n = 30) | 4 weeks | (1) |
| Wang et al[38], 2019 | 134 | E: 42.3 ± 12.34 | C: 40.57 ± 13.91 | Xiaoyao powder (n = 67) | No intervention (n = 67) | 6 months | (1)(3)(5) |
| Lin[35], 2022 | 70 | E: 47.33 ± 5.96 | C: 46.82 ± 6.14 | Jieyusanjie decoction (n = 35) | Sertraline hydrochloride tablets (n = 35) | 4 weeks | (1) |
| Xiao[39], 2021 | 100 | E: 45.81 ± 11.56 | C: 46.37 ± 12.21 | Modified Xiaoyao powder (n = 50) | Paroxetine Hydrochloride tablets (n = 50) | 3 months | (1)(4) |
| An et al[31], 2022 | 120 | E: 55.76 4 ± 8.81 | C: 56.05 ± 8. 73 | Chaihu plus Longgumuli decoction (n = 60) | Escitalopram tablets (n = 60) | 60 days | (1)(4) |
| Zhang[40], 2022 | 60 | E: 54.67 ± 6.87 | C: 54.20 ± 7.56 | Chaihushugan powder (n = 30) | Flupentixol and melitracen tablets (n = 30) | 4 weeks | (2)(3) |
| Zhong et al[41], 2023 | 106 | E: 52.09 ± 9.07 | C: 51.23 ± 8.91 | Modified Fangjidihuang (n = 53) | Sertraline hydrochloride tablets (n = 53) | 8 weeks | (1)(4) |
- Citation: Hong SC, Du YY, Wang GB, Wang SQ, Zheng YF, Wang N, Situ HL, Wang ZY. Chinese herbal formulas alleviated depression in breast cancer patients: A meta-analysis, network pharmacology and experimental validation. World J Psychiatry 2026; 16(4): 115981
- URL: https://www.wjgnet.com/2220-3206/full/v16/i4/115981.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i4.115981
